Home
About
Overview
Sharing Data
ORCID
Help
History (52)
Probabilistic Measurement of Central Line-Associated Bloodstream Infections.
Racial and socioeconomic disparities in breast milk feedings in US neonatal intensive care units.
Stein, Brian
Myogenic and central neurogenic factors in fatigue in multiple sclerosis.
Sticker shock and the price of new therapies for hepatitis C: is it worth it?
See All 52 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Sticker shock and the price of new therapies for hepatitis C: is it worth it?
Sticker shock and the price of new therapies for hepatitis C: is it worth it? Hepatology. 2014 Apr; 59(4):1246-9.
View in:
PubMed
subject areas
Antiviral Agents
Cost-Benefit Analysis
Health Care Costs
Hepatitis C, Chronic
Humans
Retrospective Studies
Treatment Outcome